Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications

The LC16m8 strain of vaccinia virus, the active ingredient in the Japanese smallpox vaccine, was derived from the Lister/Elstree strain. LC16m8 is replication-competent and has been administered to over 100,000 infants and 3,000 adults with no serious adverse reactions. Despite this outstanding safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kidokoro, Minoru, Shida, Hisatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494248/
https://www.ncbi.nlm.nih.gov/pubmed/26344890
http://dx.doi.org/10.3390/vaccines2040755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494248/
https://www.ncbi.nlm.nih.gov/pubmed/26344890
http://dx.doi.org/10.3390/vaccines2040755

Ejemplares similares